Drugs / Platelet- and extracellular vesicle-rich plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04761562 | Feb 2021 → Sep 2023 | chronic otitis media, tympanic membrane disorder | University Medical Centre Ljubljana | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet- and extracellular vesicle-rich plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04761562 ↗ |
| Known as | PVRP | “The purpose of the study is to determine whether autologous platelet- and extracellular vesicle-rich plasma (PVRP) made from peripheral venous blood, promotes healing of...” NCT04761562 ↗ |
| Modality | Other / unclassified | “This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma as a supplement to the surgical...” NCT04761562 ↗ |
| Route | Other | “PVRP will initially be applied to the gelatine sponge without prior exogenous activation, which will first be inserted into the middle ear cavity” NCT04761562 ↗ |